Paysign NASDAQ: PAYS operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation.
Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
| CXA Exchange | US Country |
Paysign, Inc. specializes in offering a broad spectrum of prepaid card programs, patient affordability options, digital banking services, and integrated payment processing for a diverse clientele including businesses, consumers, and government institutions. Initially known as 3PEA International, Inc., the company underwent a name change to Paysign, Inc. in April 2019, showcasing its evolution and broadening its focus. Founded in 1995 and operating from its headquarters in Henderson, Nevada, Paysign extends its market presence primarily towards organizations and municipalities in need of efficient payment solutions for various purposes such as rewards, rebates, and payment assistance. This rebranding and strategic positioning reflect Paysign's commitment to innovation in payment solutions.